Tectonic Therapeutic (TECX) Cash from Operations (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Cash from Operations of 18413000.0 for Q1 2026, down 40.74% year-over-year from 31071492.2 in Q1 2025, and down 27.33% quarter-over-quarter from 14461000.0 in Q4 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Cash from Operations (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Cash from Operations for 10 consecutive years, with 18413000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 40.74% year-over-year to 18413000.0; the TTM figure through Mar 2026 stood at 65408000.0 (down 4.0% YoY), while the FY2025 annual figure was 60078000.0, down 1.69% from the prior year.
- Cash from Operations declined to 18413000.0 in Q1 2026 per TECX's latest filing, from 14461000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 259000.0 in Q2 2023 and bottomed at 29106000.0 in Q2 2022.
- Historically, Cash from Operations has averaged 16203529.41 across 5 years, with a median of 16415000.0 in 2022.
- Annual changes were most pronounced in 2023 — Cash from Operations jumped 99.11% — and 2024, when it sank 5066.8%.
- Tectonic Therapeutic's Cash from Operations stood at 23673000.0 in 2022, then soared by 50.76% to 11657000.0 in 2023, then sank by 44.3% to 16821000.0 in 2024, then climbed by 14.03% to 14461000.0 in 2025, then dropped by 27.33% to 18413000.0 in 2026.
- Business Quant data shows TECX's Cash from Operations at 18413000.0 in Q1 2026, 14461000.0 in Q4 2025, and 17815000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | -21.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.45 Mn |
| Mar 31, 2026 | -18.41 Mn |
| Dec 31, 2025 | -14.46 Mn |
| Sep 30, 2025 | -17.82 Mn |
| Jun 30, 2025 | -14.72 Mn |
| Mar 31, 2025 | -13.08 Mn |
| Dec 31, 2024 | -16.82 Mn |
| Sep 30, 2024 | -19.60 Mn |
| Jun 30, 2024 | -13.38 Mn |
| Mar 31, 2024 | -9.27 Mn |
| Dec 31, 2023 | -11.66 Mn |
| Sep 30, 2023 | -8.48 Mn |
| Jun 30, 2023 | -259,000.00 |
| Mar 31, 2023 | -20.28 Mn |
| Dec 31, 2022 | -23.67 Mn |
| Sep 30, 2022 | -16.42 Mn |
| Jun 30, 2022 | -29.11 Mn |
| Mar 31, 2022 | -28.01 Mn |
| Dec 31, 2021 | -25.90 Mn |
| Sep 30, 2021 | -24.82 Mn |